UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036716
Receipt number R000041834
Scientific Title Relationship between lymphocyte count, serum zinc and copper during zinc acetate administration in hemodialysis patients with hypozinemia .
Date of disclosure of the study information 2019/06/01
Last modified on 2019/05/12 00:15:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between lymphocyte count, serum zinc and copper during zinc acetate administration in hemodialysis patients with hypozinemia
.

Acronym

Relationship between lymphocyte count, serum zinc and copper

Scientific Title

Relationship between lymphocyte count, serum zinc and copper during zinc acetate administration in hemodialysis patients with hypozinemia
.

Scientific Title:Acronym

Relationship between lymphocyte count, serum zinc and copper

Region

Japan


Condition

Condition

Lymphopenia in hemodialysis patients

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Clinical trial whether zinc acetate administration improves lymphopenia

Basic objectives2

Others

Basic objectives -Others

Examination of the change of lymphocyte count and serum zinc and copper level by zinc acetate administration.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Increased number of lymphocytes after 12 months by zinc acetate administration

Key secondary outcomes

To evaluate the safety of zinc acetate administration from clinical adverse events and serum zinc and copper levels


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administer 100mg of zinc acetate daily for 12 months to hemodialysis patients with hypozinemia and lymphopenia

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Hemodialysis patients with serum zinc level less than 65microg/dl before the study

Key exclusion criteria

Patients who did not get consent for the trial

Target sample size

23


Research contact person

Name of lead principal investigator

1st name RYOICHI
Middle name
Last name MIYAZAKI

Organization

Fujita Memorial Hospital

Division name

Internal Medicine

Zip code

910-0004

Address

4-15-7, Houei, Fukui City, Japan

TEL

0776-21-1277

Email

ryoichi@mitene.or.jp


Public contact

Name of contact person

1st name RYOICHI
Middle name
Last name MIYAZAKI

Organization

Fujita Memorial Hospital

Division name

Internal Medicine

Zip code

910-0004

Address

4-15-7, Houei, Fukui City, Japan

TEL

0776-21-1277

Homepage URL


Email

ryoichi@mitene.or.jp


Sponsor or person

Institute

Fujita Memorial Hospital

Institute

Department

Personal name



Funding Source

Organization

Fujita Memorial Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Fujita Memorial Hospital

Address

4-15-7, Houei, Fukui City, Japan

Tel

0776-21-1277

Email

ryoichi@mitene.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

藤田記念病院


Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

23

Results

Examination end

Results date posted

2019 Year 05 Month 12 Day

Results Delayed

Delay expected

Results Delay Reason

Analysis delay

Date of the first journal publication of results

2020 Year 12 Month 01 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 06 Month 15 Day

Date of IRB

2017 Year 08 Month 07 Day

Anticipated trial start date

2017 Year 07 Month 01 Day

Last follow-up date

2018 Year 09 Month 15 Day

Date of closure to data entry

2018 Year 10 Month 01 Day

Date trial data considered complete

2018 Year 10 Month 30 Day

Date analysis concluded

2019 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2019 Year 05 Month 12 Day

Last modified on

2019 Year 05 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041834


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name